Fighting Disease So More “You” Shines Through
At Acadia, we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We have developed therapies for the treatment of Rett syndrome and for hallucinations and delusions associated with Parkinson’s disease psychosis. Currently, our clinical-stage developments focus on addressing Prader-Willi syndrome, Alzheimer’s disease psychosis, and neuropsychiatric symptoms in CNS disorders.
We recently announced that Health Canada has granted market authorization for our treatment of Rett syndrome in adult and pediatric patients two years of age and older. Learn more here.
Leading the Way in Rett Syndrome Therapy
Our commitment is unwavering towards creating a brighter future for individuals living with rare diseases and their families. Our efforts continue to focus on broadening access to essential therapies for families across the globe.
